Page last updated: 2024-08-23

substance p and Anxiety Neuroses

substance p has been researched along with Anxiety Neuroses in 10 studies

Research

Studies (10)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (10.00)	18.2507
2000's	6 (60.00)	29.6817
2010's	3 (30.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Åhs, F; Appel, L; Fernandez, M; Frans, Ö; Fredrikson, M; Frick, A; Furmark, T; Jonasson, M; Lubberink, M; Palmquist, ÅM; Pissiota, A; von Knorring, L; Wallenquist, U	1
Katsouni, E; Liapi, C; Sakkas, P; Skandali, N; Zarros, A	1
Gehlert, DR; Iyengar, S; Kielbasa, W; Marek, G; Mozley, D; Peng, X; Tauscher, J; Vandenhende, F	1
Almeida, CR; Andrade, AF; Andrade, RM; Araújo-Lima, CF; Barros, PO; Bento, CA; Ferreira, TB; Hygino, J; Silva-Filho, RG; Vieira, MM	1
Mantyh, PW	1
Krishnan, R; Ranga, K	1
Santarelli, L; Saxe, MD	1
Jonas, C	1
Nutt, D	1
Berger, M; Fiebich, BL; Lieb, K	1

Reviews

4 review(s) available for substance p and Anxiety Neuroses

Article	Year
The involvement of substance P in the induction of aggressive behavior. Peptides, 2009, Volume: 30, Issue:8 Topics: Aggression; Animals; Anxiety Disorders; Humans; Mood Disorders; Rage; Receptors, Neurokinin-1; Substance P	2009
Neurobiology of substance P and the NK1 receptor. The Journal of clinical psychiatry, 2002, Volume: 63 Suppl 11 Topics: Affect; Animals; Antidepressive Agents; Anxiety Disorders; Brain; Cell Death; Cells, Cultured; Depressive Disorder; Humans; Immunotoxins; Killer Cells, Natural; Mice; Models, Animal; Rats; Receptors, Immunologic; Receptors, Neurokinin-1; Ribosome Inactivating Proteins, Type 1; Saporins; Spinal Cord; Substance P	2002
Substance P antagonists: meet the new drugs, same as the old drugs? Insights from transgenic animal models. CNS spectrums, 2003, Volume: 8, Issue:8 Topics: Animals; Anti-Anxiety Agents; Antidepressive Agents; Anxiety Disorders; Brain; Clinical Trials as Topic; Depressive Disorder; Disease Models, Animal; Drug Evaluation, Preclinical; Drugs, Investigational; Humans; Mice; Mice, Transgenic; Receptors, Neurokinin-1; Substance P	2003
[Substance P receptor antagonists--a new antidepressive and anxiolytic mechanism?]. Der Nervenarzt, 2000, Volume: 71, Issue:9 Topics: Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Anxiety Disorders; Aprepitant; Depression; Humans; Morpholines; Neurokinin-1 Receptor Antagonists; Substance P	2000

Trials

3 trial(s) available for substance p and Anxiety Neuroses

Article	Year
Development of the 2nd generation neurokinin-1 receptor antagonist LY686017 for social anxiety disorder. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2010, Volume: 20, Issue:2 Topics: Adult; Animals; Anti-Anxiety Agents; Anxiety Disorders; Brain; Dose-Response Relationship, Drug; Gerbillinae; Humans; Male; Neurokinin-1 Receptor Antagonists; Paroxetine; Peptide Fragments; Pyridines; Radioligand Assay; Radionuclide Imaging; Receptors, Neurokinin-1; Stereotyped Behavior; Substance P; Treatment Outcome; Triazoles	2010
Clinical experience with substance P receptor (NK1) antagonists in depression. The Journal of clinical psychiatry, 2002, Volume: 63 Suppl 11 Topics: Antidepressive Agents; Anxiety Disorders; Aprepitant; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Ethers; Female; Humans; Hydrocarbons, Fluorinated; Male; Morpholines; Neurokinin-1 Receptor Antagonists; Paroxetine; Placebos; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Substance P; Treatment Outcome	2002
Substance-P antagonists: a new treatment for depression? Lancet (London, England), 1998, Nov-21, Volume: 352, Issue:9141 Topics: Antidepressive Agents, Second-Generation; Anxiety Disorders; Aprepitant; Depressive Disorder; Double-Blind Method; Humans; Morpholines; Paroxetine; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Substance P	1998

Other Studies

3 other study(ies) available for substance p and Anxiety Neuroses

Article	Year
Overlapping expression of serotonin transporters and neurokinin-1 receptors in posttraumatic stress disorder: a multi-tracer PET study. Molecular psychiatry, 2016, Volume: 21, Issue:10 Topics: Adult; Amygdala; Aniline Compounds; Anxiety Disorders; Brain; Case-Control Studies; Cerebral Cortex; Female; Humans; Male; Piperidines; Positron-Emission Tomography; Receptors, Neurokinin-1; Serotonin; Serotonin Plasma Membrane Transport Proteins; Stress Disorders, Post-Traumatic; Substance P; Sulfides; Tetrazoles; Transcriptome	2016
Substance P enhances Th17 phenotype in individuals with generalized anxiety disorder: an event resistant to glucocorticoid inhibition. Journal of clinical immunology, 2011, Volume: 31, Issue:1 Topics: Adolescent; Adult; Anxiety Disorders; Cells, Cultured; Drug Resistance; Female; Glucocorticoids; Humans; Lymphocyte Activation; Male; Phenotype; Substance P; T-Lymphocytes; Th17 Cells; Young Adult	2011
[Fibromyalgia: rheumatologic or psychiatric disease?]. Presse medicale (Paris, France : 1983), 2006, Volume: 35, Issue:11 Pt 2 Topics: Adult; Anxiety Disorders; Child; Diagnosis, Differential; Fibromyalgia; Genetic Predisposition to Disease; Humans; Mental Disorders; Prevalence; Risk Factors; Somatoform Disorders; Stress Disorders, Post-Traumatic; Substance P	2006